Apr 21, 2021 / 12:00PM GMT
Operator
Ladies and gentlemen, welcome to the Xvivo Group interim report Q1 2021. (Operator Instructions) I will now hand it over to CEO, Dag Andersson. Please go ahead with your meeting.
Dag Andersson - Xvivo Perfusion AB(publ)-President&CEO
Thank you very much for the introduction. So dear all, welcome to the first quarterly telephone conference 2021. And I am happy to present to you, together with my CFO, Kristoffer Nordstrom.
And as mentioned in the quarterly report released this morning, the year has started well for XVIVO and quarter 1 was positive from many different aspects. And both sales margins, EBITDA showed positive performance or very positive performance, sales up 38% in the quarter. We had a gross margin of 75%, and EBITDA margin adjusted of 11%. And also worth mentioning strong organic growth of 10%.
And particularly positive was the development of thoracic machine perfusion sales, which increased by 45% versus same quarter last year. This is actually an outstanding number, bearing
Q1 2021 Xvivo Perfusion AB Earnings Call Transcript
Apr 21, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers